Related Experiment Video
Updated: Jan 20, 2026

Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo
Published on: June 2, 2019
Aβ42 fibril formation from predominantly oligomeric samples suggests a link between oligomer heterogeneity and fibril
Christine Xue1, Joyce Tran1, Hongsu Wang1
1Department of Neurology, Brain Research Institute, Molecular Biology Institute, University of California, 710 Westwood Plaza, Los Angeles, CA 90095, USA.
Abstract:
Amyloid-β (Aβ) oligomers play a central role in the pathogenesis of Alzheimer's disease. Oligomers of different sizes, morphology and structures have been reported in both in vivo and in vitro studies, but there is a general lack of understanding about where to place these oligomers in the overall process of Aβ aggregation and fibrillization. Here, we show that Aβ42 spontaneously forms oligomers with a wide range of sizes in the same sample. These Aβ42 samples contain predominantly oligomers, and they quickly form fibrils upon incubation at 37°C. When fractionated using ultrafiltration filters, the samples enriched with smaller oligomers form fibrils at a faster rate than the samples enriched with larger oligomers, with both a shorter lag time and faster fibril growth rate. This observation is independent of Aβ42 batches and hexafluoroisopropanol treatment. Furthermore, the fibrils formed by the samples enriched with larger oligomers are more readily solubilized by epigallocatechin gallate, a main catechin component of green tea. These results suggest that the fibrils formed by larger oligomers may adopt a different structure from fibrils formed by smaller oligomers, pointing to a link between oligomer heterogeneity and fibril polymorphism.
Insights
Alzheimer's disease involves amyloid-β (Aβ) oligomers. Smaller Aβ42 oligomers aggregate into fibrils faster than larger ones, suggesting a link between oligomer size and Alzheimer's disease progression.
Area of Science:
- Neuroscience
- Biochemistry
- Molecular Biology
Background:
- Amyloid-β (Aβ) oligomers are central to Alzheimer's disease pathogenesis.
- Understanding the role of diverse Aβ oligomer sizes in aggregation and fibrillization remains incomplete.
Purpose of the Study:
- To investigate the relationship between Aβ42 oligomer size heterogeneity and subsequent fibril formation kinetics.
- To explore how oligomer size influences the structural properties and solubilization of resulting amyloid fibrils.
Main Methods:
- Fractionation of Aβ42 oligomers using ultrafiltration.
- Monitoring fibril formation kinetics (lag time and growth rate) at 37°C.
- Assessing fibril solubilization using epigallocatechin gallate.
Main Results:
- Aβ42 spontaneously forms a heterogeneous mixture of oligomers.
- Smaller oligomer fractions exhibited faster fibril formation rates (shorter lag time, faster growth) compared to larger oligomer fractions.
- Fibrils derived from larger oligomers were more susceptible to epigallocatechin gallate-induced solubilization, suggesting structural differences.
Conclusions:
- Oligomer size heterogeneity in Aβ42 samples influences fibril formation kinetics.
- Distinct Aβ oligomer sizes may lead to structurally different amyloid fibrils, contributing to fibril polymorphism in Alzheimer's disease.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
X-linked Traits
Single Nucleotide Polymorphisms-SNPs

